Returning to the heart of Europe, Cannabis Europa Paris 2026 brings together leaders from business, policy, healthcare, and investment to shape the future of cannabis on the continent. As regulatory landscapes shift and patient demand continues to rise, Paris becomes the stage for open dialogue, fresh perspectives, and new opportunities.
Cannabis Europa Paris is organised in partnership with UIVEC, the representative trade association for the cannabinoid and medical cannabis sector in France. It brings together more than sixty agricultural and economic players located throughout the value chain of hemp extracts, such as CBD or THC.
Our speakers are global thought-leaders driving change in policy, research, and commerce. Hear their insights, challenge your thinking, and leave with actionable strategies.
Cannabis Europa Paris 2026 brings together policymakers, clinicians, industry leaders and international experts for a full-day agenda exploring France’s transition from pilot to national medical cannabis access. Across keynotes, policy deep-dives, clinical pathway sessions, market development panels and comparative insights from Canada, Luxembourg and Switzerland, the programme examines the decisions shaping patient access, pharmaceutical standards, reimbursement models and domestic production. Delegates will gain a clear understanding of France’s 2026 framework, practical operational implications for healthcare and industry, and the broader European signals emerging from this historic moment in cannabis policy reform.
The Infrastructure of Access: Can Europe Scale to 5,000,000 Medical Cannabis Patients?
State of Play Session: Czech Republic
State of Play Session: Switzerland
Join the leading voices in cannabis policy and business. We’re proud to partner with organisations at the forefront of cannabis innovation, investment, and regulation.
We’re pleased to offer exclusive rates at our partner hotels for Cannabis Europa Paris attendees.
Use promo code UIVEC for 30% off public rates on our official websites for stays between 18-22 February 2026.
*Offer excludes any promotions already in place and cannot be combined. *Offer valid for the accommodation portion only.
Visit the hotel websites below and enter the code UIVEC in the PROMO CODE field. Your discount will be applied automatically when you select your room.
Subscribe to receive the latest updates on cannabis regulation, investment, and innovation in Europe.
Join the leading voices in cannabis policy and business. Find out who is attending Cannabis Europa Paris 2026.
Cannabis Europa brings together the brightest minds in cannabis policy, business, and investment. You’ll engage with policymakers, investors, scientists, and entrepreneurs to explore opportunities in one of the world’s fastest-evolving markets.
The debate around cannabis reform in the United Kingdom has grown more structured, more evidence-based, and more commercially significant in recent years. Yet legislative change at the national level remains absent. Understanding why — and what the realistic trajectory looks like — matters as much to investors and business leaders as it does to policymakers […]
The European cannabis landscape is entering a high-growth phase, marked by the arrival of seasoned entrepreneurs and major institutional shifts. As Cannabis Europa London 2026 approaches, the first wave of speakers has been announced, highlighting a diverse intersection of pharmaceutical innovation, global policy, and venture capital. Martin Dickie MBE & Waterside Pharmaceuticals A major highlight […]
With dedicated sessions on M&A, investment, pricing strategy and market access, Cannabis Europa London 2026 is the room where Europe’s cannabis industry does business. There are cannabis conferences, and then there are the events where decisions actually get made. Cannabis Europa London has established itself as the latter—a curated gathering of the operators, investors, policymakers […]
Germany and Poland are tightening the rules on online prescribing. The ripple effects will reshape medical cannabis access across the continent. Telemedicine didn’t just support the growth of European medical cannabis—it turbocharged it. Online consultations and e-prescriptions lowered barriers for patients, expanded clinic reach beyond urban centres, and drove a surge in imports across the […]
